Tyra Biosciences, Inc.
TYRA
$25.38
$0.361.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.56M | -39.31M | -33.83M | -29.87M | -28.10M |
| Total Depreciation and Amortization | 138.00K | 138.00K | 132.00K | 131.00K | 140.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.03M | 7.82M | 7.50M | 7.16M | 5.67M |
| Change in Net Operating Assets | 4.32M | -1.23M | 2.58M | 199.00K | -1.39M |
| Cash from Operations | -31.08M | -32.57M | -23.62M | -22.38M | -23.68M |
| Capital Expenditure | -66.00K | -88.00K | -57.00K | -39.00K | -31.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.92M | -120.16M | 34.43M | -14.77M | 20.90M |
| Cash from Investing | 17.85M | -120.24M | 34.38M | -14.81M | 20.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.10M | 162.48M | 4.68M | 647.00K | 583.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -2.10M | -- | -- | -- |
| Cash from Financing | 2.10M | 160.38M | 4.68M | 647.00K | 583.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.12M | 7.57M | 15.44M | -36.54M | -2.23M |